Market Pulse LIVECAST Terminal Brief Politics Macro Calendar

More

Stocks About Why SquawkNews Newsroom Schedule Prediction Markets Disclosure Wire Crypto Search

Market Pulse LIVECAST

Menu

Home Market Pulse LIVECAST Terminal Brief Politics Macro Calendar Stocks About Why SquawkNews Newsroom Schedule Prediction Markets Disclosure Wire Crypto Search

Live News EQUITY L impact Jul 15, 2026, 11:04 AM UTC

MANE new Buy W/ $170 PT @ BRiley

MANE new Buy W/ $170 PT @ BRiley

SquawkNews Newsroom

MANE new Buy W/ $170 PT @ BRiley

Use this page

Share or save this market-moving headline as a permanent SquawkNews URL. The live feed continues at /news.

Open live news feed Browse news archive Browse news categories Search related coverage

Related tickers

W

Related stories

LDI randian capital: calls on loandepot board to evaluate strategic alternatives LDI randian capital: calls on loandepot board to evaluate strategic alternatives L impact | EQUITY | Jul 15, 2026, 12:02 PM UTC VISN Aurora Networks, a Vistance Networks unit, expanded its distributed access footprint at Liberty Puerto Rico with a Remote MACPHY deploy VISN Aurora Networks, a Vistance Networks unit, expanded its distributed access footprint at Liberty Puerto Rico with a Remote MACPHY deployment. Liberty installed Aurora’s RD2322 L impact | EQUITY | Jul 15, 2026, 12:02 PM UTC AMIX Autonomix Medical granted U.S. patent for overactive bladder diagnosis and treatment platform AMIX Autonomix Medical granted U.S. patent for overactive bladder diagnosis and treatment platform L impact | EQUITY | Jul 15, 2026, 12:02 PM UTC CLSK Reiterate Overweight, $26 PT (from $17) following lease agreement @ Cantor CLSK Reiterate Overweight, $26 PT (from $17) following lease agreement @ Cantor L impact | EQUITY | Jul 15, 2026, 12:01 PM UTC RANI Therapeutics announces positive initial phase 1a data for rt-114 for the treatment of obesity, with oral bioavailability exceeding matc RANI Therapeutics announces positive initial phase 1a data for rt-114 for the treatment of obesity, with oral bioavailability exceeding matched subcutaneous dosing Rani Therapeutic L impact | EQUITY | Jul 15, 2026, 12:01 PM UTC PAGS downgraded from Buy to Neutral W/ $10 PT (From $12) @ BAML PAGS downgraded from Buy to Neutral W/ $10 PT (From $12) @ BAML L impact | EQUITY | Jul 15, 2026, 12:01 PM UTC

SQUAWK/NEWS

Real-time financial news agency. Market-moving headlines, macro, politics, filings and audio squawk built for traders.

Product

LiveCast
Terminal
Brief
Macro
Calendar
Search

For Traders

News for Traders
How to Trade News
What Is a Squawk
Market Pulse
Disclosure Wire

Company

About
Why SquawkNews
Newsroom
Editorial Standards
Corrections
Contact

© 2026 SquawkNews robots / sitemap SquawkNews publishes factual market information and context. It is not investment advice and does not provide trade recommendations.